Targeting calcium channels to block tumor vascularization

Area of Science:

• Cardiovascular Biology
• Oncology
• Cellular Physiology

Background:

• Endothelial cells (ECs) exhibit versatile functions in physiological and pathological states.
• Tumor vasculature possesses unique features due to tumor-derived ECs (TECs), offering potential therapeutic targets.
• Calcium signaling is crucial for EC function and angiogenesis, regulated by various channels and mechanisms.

Purpose of the Study:

• To review the current understanding of calcium signaling in tumor vascularization.
• To highlight the differences between normal ECs and TECs regarding calcium signaling.
• To identify potential molecular targets for cancer therapy based on vascular calcium signaling.

Main Methods:

• Literature review of recent research and patents on calcium signaling and tumor vascularization.
• Analysis of studies investigating calcium signaling in normal ECs and TECs.
• Focus on TRP and Orai calcium channels and their regulation.

Main Results:

• Normal ECs utilize TRP and Orai channels for proangiogenic calcium signaling, regulated by lipids, post-translational modifications, and membrane trafficking.
• Preliminary studies show altered calcium signals and TRP channel function in breast and renal TECs.
• TECs exhibit distinct calcium signaling profiles compared to normal ECs.

Conclusions:

• Calcium signaling in TECs is a critical area for further investigation.
• Targeting specific calcium channels in tumor vasculature may offer novel anti-cancer strategies.
• Future research should focus on characterizing TEC calcium signaling for therapeutic development.